In one study, researchers found a reduction of weight; resolution of hypertriglyceridemia, low HDL-cholesterol, and impaired fasting glycemia; and normalization of alanine aminotransferase in men with severe obesity and NAFLD [22]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.